Looking for a specific product?

Make a search for products & suppliers, articles & news.

Bionor Pharma ASA - Successful completion of subsequent offering

Reference is made to the prospectus dated 7 October 2013 and the stock exchange announcement dated 8 October 2013 concerning the subsequent offering (the "Subsequent Offering") of up to 7,500,000 shares (the "Offer Shares") in Bionor Pharma ASA (the "Company") at a subscription price of NOK 2.75 per share. The Company reports that the Subsequent Offering was oversubscribed. 

The subscription period in the Subsequent Offering ended on 22 October 2013 at 16.30 (CET). As a result of the Subsequent Offering, the Company will issue 7,500,000 Offer Shares at NOK 2.75 per share raising gross proceeds of approximately NOK 20.6 million.

All subscribers being allotted Offer Shares will receive a letter confirming the number of Offer Shares allotted to the subscriber and the corresponding amount to be paid. This letter is expected to be distributed on or about today's date.

To read more, please visit Bionor Pharma's website.

Associated companies:


Related news

Latest news

PRESS RELEASE: Servogear to propel Asian built windfarm vessels

The contract with Cheoy Lee Shipyards was signed in Q2 2018.

SERVICEBULLETIN: Grease filling of the propeller system

SERVICEBULLETIN 180921: Grease filling of the propeller system

FILM: The world´s first HD220 gearbox returns for an overhauling

The gearbox has been operating flawlessly for more than 20.000 hours...

Øveraasen delivers machine number 66 to New York

Totally over the last ten years, 

DNV GL commission worlds largest industrial explosion chamber at Spadeadam Research and Testing

The chamber supports not only a joint industry project ...

DNV GL celebrates double win at Lloyd’s List Asia Pacific Awards

We would like to thank all of the judges and Lloyd’s List for these awards,

WITH OR WITHOUT SKIRTINGS?

A theme that often comes back to me while working with new customers is the flooring,

Heating cable segment officially transferred to ØS Varme

Øglænd System AS’s future strategy will be focused on the sale...

Genesis is celebrating its 30th anniversary

TechnipFMC’s market-leading engineering and advisory company,